
|Articles|December 1, 2003
Opinions Vary on New Fillers
The choice of injectable fillers that have been approved or are coming up for approval by the FDA is growing almost daily. From temporary materials such as Collagen and Restylane to longer-lasting substances such as Artecoll and Radiance, an array of products to augment the soft tissue in the face will soon be available from which patients can choose.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














